Edwards Lifesciences exec exercises and sells shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Wayne Markowitz, CVP, JAPAC at Edwards Lifesciences, exercised employee stock options covering 9,628 shares of common stock at $74.02 per share on July 28, 2026, then sold 9,628 shares at $85.06 per share the same day. Following the exercise, 9,628 derivative option securities are reported as held.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Acquire) | 9,628 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,628 | $74.02 | $713K |
| Sale | Common Stock | 9,628 | $85.06 | $819K |
Key Figures
Key Terms
Employee Stock Option (Right to Acquire) financial
derivative security financial
beneficial ownership financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Wayne Markowitz report for Edwards Lifesciences (EW)?
What options did Wayne Markowitz exercise in his Edwards Lifesciences (EW) filing?
Were any derivative securities still held by Wayne Markowitz after the Edwards Lifesciences (EW) transactions?
Was Wayne Markowitz’s Edwards Lifesciences (EW) trade part of a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.